You are here

  • Home
  • Archive
  • Volume 67, Issue 8
  • Does the use of tumour necrosis factor antagonist therapy in poor prognosis, undifferentiated arthritis prevent progression to rheumatoid arthritis?

Article info

Article menu
Download PDFPDF
Concise report
Does the use of tumour necrosis factor antagonist therapy in poor prognosis, undifferentiated arthritis prevent progression to rheumatoid arthritis?

Authors

  1. Professor P Emery, Academic Section of Musculoskeletal Disease, University of Leeds, Chapel Allerton Hospital, Chapeltown Rd, Leeds LS7 4SA, UK; p.emery{at}leeds.ac.uk
View Full Text

Citation

Saleem B, Mackie S, Quinn M, et al
Does the use of tumour necrosis factor antagonist therapy in poor prognosis, undifferentiated arthritis prevent progression to rheumatoid arthritis?
Annals of the Rheumatic Diseases 2008;67:1178-1180.

Publication history

  • Accepted January 17, 2008
  • First published January 30, 2008.
Online issue publication 
April 24, 2023

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

2008 BMJ Publishing Group and European League Against Rheumatism